Trials / Recruiting
RecruitingNCT04537390
Anti-mullerian Hormone Levels in Healthy Females
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Erin Rowell · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to have a better understanding of the normal blood levels of AMH in females from 0-18 years of age and how the blood AMH levels correspond to a female's reproductive development.
Detailed description
Anti-mullerian hormone (AMH) is a chemical in the body that is found in the blood that can estimate the ability of a female to have her own children. It is widely used in adult female cancer patients to predict the onset of menopause and/or the inability to have children that can be associated with chemotherapy and/or radiation treatment. Normal blood levels of AMH are better understood in adults than in children and adolescents. The purpose of this study is to have a better understanding of the normal blood levels of AMH in females from 0-18 years of age and how the blood AMH levels correspond to a female's reproductive development. With a better understanding of normal AMH levels in children, we may be able to better assess a girl's risk of not being able to have children if she is a cancer patient, and may be able to offer her and her family options to increase the chances of having her own children.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Blood sample collection | Blood samples are collected for diagnostically assessing how the blood AMH levels correspond to a female's reproductive development |
Timeline
- Start date
- 2016-07-19
- Primary completion
- 2030-12-01
- Completion
- 2030-12-01
- First posted
- 2020-09-03
- Last updated
- 2024-11-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04537390. Inclusion in this directory is not an endorsement.